Close Menu

NEW YORK (360Dx) – Singapore cancer diagnostics firm Clearbridge BioMedics said today that it has secured S$6.6 million ($4.8 million) in funding ahead of a planned initial public offering.

According to the company, the round drew interest from both biotech investors, and from medical professionals in the oncology space. Money raised will support Clearbridge's business expansion, technology development, talent recruitment, and expenses related to its potential listing.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.